Bartter disease type 4b is a rare genetic kidney condition that causes salt loss and dehydration. Features often include frequent urination, craving for salt, muscle cramps, and poor growth in infants and children. Many people with Bartter disease type 4b also have hearing loss that is present from birth or early childhood. It is lifelong, but treatment with salt and potassium supplements, magnesium, plenty of fluids, and medicines like NSAIDs can help. The outlook varies, but with regular kidney and hearing care many people live well into adulthood.
Overview
Bartter disease type 4bSymptoms
Bartter disease type 4b often appears before birth with excess amniotic fluid, then in infancy with heavy urination, thirst, dehydration, and poor growth. Blood tests show low potassium and alkaline blood. Permanent inner-ear hearing loss is common.
Outlook and prognosis
Many living with Bartter disease type 4b can lead active lives with careful, ongoing care. Early treatment of salt loss, potassium balance, kidney protection, and hearing support often improves growth, strength, and daily energy. Long-term outlook varies; regular specialist follow-up helps prevent kidney damage.
Causes and risk factors
Bartter disease type 4b usually results from inherited changes in both CLCNKA and CLCNKB (digenic recessive). Risk rises with family history or parental relatedness. Illness, heat, dehydration, and low salt intake don’t cause it but can worsen severity.
Genetic influences
Genetics are central in Bartter disease type 4b. It’s usually caused by inherited changes in two partner genes (BSND plus CLCNKA or CLCNKB), typically in an autosomal recessive pattern. Variations influence severity, age at onset, electrolyte losses, and hearing involvement.
Diagnosis
Doctors suspect Bartter disease type 4b from clinical features and characteristic lab findings, often in infancy. Genetic tests confirming pathogenic variants provide the genetic diagnosis of Bartter disease type 4b; hearing screening and electrolyte panels usually support it.
Treatment and drugs
Treatment for Bartter disease type 4b focuses on steady electrolyte replacement (potassium, magnesium, sodium), careful fluid balance, and medicines that reduce salt loss by the kidneys. Many also benefit from prostaglandin blockers and acid–base correction. Hearing support, including hearing aids or cochlear implants, is often considered.
Symptoms
Many families first notice a baby who pees a lot, seems very thirsty, and struggles to gain weight. Parents often first notice early features of Bartter disease type 4b in infancy, and hearing differences may be present from birth. Features vary from person to person and can change over time. As children grow, ongoing salt and water loss can lead to fatigue, muscle cramps, and dehydration, especially during illness or hot weather.
Passing large amounts of urine many times a day. This can mean very wet diapers or needing the toilet often at school.
Strong, ongoing thirst with frequent drinking. In Bartter disease type 4b, people may wake at night to drink and carry water everywhere.
A strong preference for salty foods or adding extra salt. The body is trying to replace salt lost in the urine. This craving is common in Bartter disease type 4b.
Dry mouth, dizziness, or headaches when fluids or salt run low. Episodes can be triggered by heat, exercise, fevers, or stomach bugs. Quick rehydration often helps people feel better.
How people usually first notice Bartter disease type 4b?
People often first notice Bartter disease type 4b in infancy when a baby isn’t gaining weight as expected, seems unusually thirsty, urinates often, and may have episodes of dehydration despite good feeding. Doctors are alerted by blood tests showing low potassium and metabolic alkalosis, very high urine salt losses, and, in many cases, early hearing concerns because this subtype is linked with sensorineural hearing loss; newborn hearing screening or caregiver worries about not responding to sound can be an early clue. These early features—frequent wet diapers, poor growth, dehydration, and possible hearing issues—are the most common first signs of Bartter disease type 4b.
Types of Bartter disease type 4b
Bartter disease type 4b is a rare genetic kidney condition with a few recognized clinical variants tied to which gene is affected and how much function remains. These variants can shape age at diagnosis, how often dehydration episodes occur, growth patterns, and whether hearing is involved. People may notice different sets of symptoms depending on their situation. Knowing the main variants of Bartter disease—and how they differ—can help you and your care team talk about types of Bartter disease and plan monitoring.
CLCNKA-dominant variant
Changes mainly affect the CLCNKA chloride channel, with some preserved CLCNKB function. Symptoms can include salt wasting, frequent urination, and dehydration starting in infancy or early childhood. Hearing loss may be mild or absent compared with other variants.
CLCNKB-dominant variant
Gene changes chiefly disrupt the CLCNKB channel, with partial CLCNKA function left. Many experience low potassium, muscle cramps, and poor weight gain, often noticed in early childhood. Hearing involvement can occur but varies in severity.
Combined 4b signature
Both CLCNKA and CLCNKB are impacted in the 4b pattern, but residual activity differs by mutation. For many, this can mean earlier and more frequent dehydration episodes, growth delay, and more consistent hearing loss. Care teams often tailor fluids, electrolytes, and hearing checks based on the balance of channel function.
What genetics can tell you about symptoms
People with Bartter disease type 4b often have severe salt loss causing dehydration, muscle cramps, and low blood pressure, plus hearing loss. This happens when both BSND and CLCNKA/CLCNKB gene changes disrupt kidney chloride channels and barttin, impairing salt balance and inner ear function.
Causes and risk factors
Bartter disease type 4b is caused by inherited changes in two kidney channel genes called CLCNKA and CLCNKB.
Risk is highest when both parents are carriers, especially if they are related.
Heat, dehydration, or stomach bugs can worsen salt loss and symptoms, but they do not cause the disease.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
If your family has early symptoms of Bartter disease type 4b in a child, genetic counseling and carrier testing can help estimate future risk.
Environmental and biological risk factors
For Bartter disease type 4b, most known influences come from biology present before birth. Doctors often group risks into internal (biological) and external (environmental). Based on current evidence, environmental links have not been shown, and risk factors for Bartter disease type 4b are largely inborn. Research continues, but no common exposures in pregnancy have been proven to raise risk.
An inherent issue in kidney salt and chloride handling set early in development drives the condition. This biological predisposition, present from birth, is the main driver rather than outside exposures.
No established environmental triggers have been shown to increase the likelihood of Bartter disease type 4b. Routine exposures such as air pollution, household chemicals, or diet have not been linked.
Common pregnancy conditions like hypertension, thyroid disorders, or diabetes have not been shown to cause Bartter disease type 4b. Current data do not support these as risk factors.
Use of typical prescription or over-the-counter medicines during pregnancy has not been linked to Bartter disease type 4b. If concerns arise about any specific drug, discuss them with your prenatal care team.
Genetic risk factors
Genetic changes drive Bartter disease type 4b. Some risk factors are inherited through our genes. In most families with early symptoms of Bartter disease type 4b, the condition results from a combined effect of changes in two kidney chloride channel genes. This pattern is called digenic autosomal recessive inheritance and explains why parents are typically healthy carriers.
Digenic recessive pattern: Two different genes must both carry non-working changes for the condition to appear. One change is in CLCNKA and the other is in CLCNKB. Parents often each carry one change but have no symptoms.
CLCNKA variants: A disease-causing change in CLCNKA alone usually does not cause Bartter disease type 4b. When paired with a change in CLCNKB, it disrupts chloride flow in the kidney and inner ear. This combined loss underlies the hearing loss seen in many with the condition.
CLCNKB variants: A single CLCNKB change by itself may not lead to symptoms in type 4b. Together with a CLCNKA change, it creates the digenic combination that causes Bartter disease type 4b. Different variant types can influence how severe features become.
Carrier parents: Each parent typically carries one altered gene and is healthy. With this digenic autosomal recessive pattern, each pregnancy has a 25% chance of a child inheriting both changes and having Bartter disease type 4b. Siblings may be healthy carriers even if they have no symptoms.
Family history: A history of newborn salt-wasting with hearing loss in siblings or close relatives may point to this genetic form. Because the variants can be passed quietly through generations, family members may wish to consider carrier testing. Genetic counseling can explain who in the family is most likely to be a carrier.
Variant severity: Not all genetic changes have the same impact. Some reduce channel function partially, while others stop it almost completely. This helps explain why clinical features can vary among people with Bartter disease type 4b.
Lifestyle risk factors
Bartter disease type 4b is a genetic tubulopathy present from birth; lifestyle habits do not cause it. However, how lifestyle affects Bartter disease type 4b can influence symptoms, electrolyte balance, kidney complications, and day‑to‑day wellbeing. The points below focus on practical ways habits can support medical treatment and reduce flares of dehydration, hypokalemia, and nephrocalcinosis.
Regular, generous fluid intake helps prevent dehydration from renal salt-wasting and polyuria. Increase fluids during fever, heat, or exercise when losses rise. Aim for steady intake across the day rather than large single boluses.
Follow the prescriber’s sodium plan to maintain blood volume and energy. Unplanned sodium restriction can worsen dizziness, cramps, and growth concerns. Adjust salt with clinician guidance during illness or heavy sweating.
Foods like potatoes, bananas, beans, and leafy greens can help support low potassium levels. Diet complements but usually does not replace prescribed potassium supplements. Monitor for symptoms like weakness or palpitations and follow lab-guided targets.
Low magnesium can worsen potassium loss and muscle symptoms in Bartter syndromes. Include magnesium-containing foods such as nuts, seeds, legumes, and greens if tolerated. Coordinate with any prescribed magnesium to avoid diarrhea or under-replacement.
Risk prevention
Because Bartter disease type 4b is inherited, you can’t prevent the condition itself in someone who has it. Prevention is about lowering risk, not eliminating it completely. The focus is on avoiding dehydration, protecting the kidneys and hearing, and catching problems early. Knowing early symptoms of Bartter disease type 4b—such as poor feeding, excessive urination, or fast breathing—can prompt faster care and fewer complications.
Regular visits with a kidney specialist and audiologist help spot changes early. In Bartter disease type 4b, routine blood tests for salts and kidney function guide treatment.
Keep steady fluid and salt intake as advised to prevent dehydration. People with Bartter disease type 4b often need extra salt and minerals adjusted with labs.
During vomiting, diarrhea, or fever, increase fluids and follow a sick-day plan from your clinic. Early contact with your care team can prevent hospital visits.
Take prescribed medicines exactly as directed, such as supplements or prostaglandin-blocking drugs. In Bartter disease type 4b, skipping doses can quickly upset salts and strain the kidneys.
Transmission
Bartter disease type 4b isn’t contagious—you can’t catch it from someone or spread it through touch, air, food, or sex. It’s a genetic condition present from birth, usually inherited in an autosomal recessive way that involves changes in two related kidney salt‑handling genes; a child typically needs to receive the nonworking versions from both parents for the condition to appear. If both parents are healthy carriers, the chance of an affected child can be about 25% in each pregnancy, though the exact risk may vary based on which gene changes run in the family. A genetics professional can explain the genetic transmission of Bartter disease type 4b and your family’s specific chances.
When to test your genes
Test your genes when you or your child has lifelong low potassium, metabolic alkalosis, salt wasting, or sensorineural hearing loss—especially if symptoms began in infancy or run in the family. Genetic testing confirms the diagnosis, guides treatment, and informs carrier risks. Test sooner if planning a pregnancy or considering IVF.
Diagnosis
Bartter disease type 4b is usually identified by a pattern of early salt-wasting symptoms and hearing changes, then confirmed with specific tests. Newborns and young children may have frequent urination, trouble gaining weight, and strong thirst; some also have sensorineural hearing loss that prompts audiology testing. Early and accurate diagnosis can help you plan ahead with confidence. Doctors then use lab work, imaging, hearing tests, and genetic testing to confirm the diagnosis and guide care.
Providers look for signs of salt loss such as frequent urination, dehydration, poor growth, and normal-to-low blood pressure. Hearing changes, especially early sensorineural hearing loss, raise suspicion for type 4 forms. Prenatal history of excess amniotic fluid can also be a clue.
Tests often show low potassium and low chloride with metabolic alkalosis. Kidney function may be normal at first but is monitored over time.
Urine electrolytes typically show high losses of sodium, chloride, and potassium. High urine calcium can occur and supports a renal salt-wasting pattern.
Blood tests frequently show high renin and aldosterone despite low or normal blood pressure. This pattern supports a kidney-based salt loss rather than hormone overproduction.
Stages of Bartter disease type 4b
Bartter disease type 4b does not have defined progression stages. This inherited kidney condition is present from birth and tends to fluctuate with salt and fluid balance rather than moving through predictable steps; hearing differences are usually identified early and often remain stable. Different tests may be suggested to help confirm the diagnosis and monitor health, including blood and urine checks for salts and acid–base balance, hearing testing, and sometimes genetic testing. Doctors may ask about early symptoms of Bartter disease type 4b, growth, dehydration episodes, and family history to guide care over time.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the short answer is that most people with Bartter disease type 4b grow up and live into adulthood, but they may need lifelong care to keep salts and fluids in balance. Early care can make a real difference, especially in babies, by preventing dehydration, protecting kidney function, and supporting growth. Hearing loss is common in Bartter disease type 4b, so timely hearing support improves language and learning. Severe dehydration, low potassium, and high urine output can cause hospital stays in infancy and childhood, but with a steady plan—salt and fluid replacement, potassium and magnesium supplements, and medicines to reduce salt wasting—many children stabilize. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Looking at the long-term picture can be helpful. Over time, the main risks are chronic kidney disease from years of salt loss and calcium deposits in the kidneys, along with ongoing hearing challenges. A small number progress to kidney failure in adolescence or adulthood, especially if dehydration or very low potassium repeats; when this occurs, dialysis or transplant can restore health. Infant mortality is higher when diagnosis and treatment are delayed, but with modern care, deaths from Bartter disease type 4b are uncommon beyond early childhood. Early symptoms of Bartter disease type 4b—poor weight gain, frequent urination, vomiting, and dehydration—tend to ease as care is optimized, though heat, stomach bugs, or missed medicines can trigger setbacks.
The outlook is not the same for everyone, but most families find a rhythm that keeps school, work, and daily life on track. With ongoing care, many people maintain normal growth and good energy, and hearing devices support communication. Talk with your doctor about what your personal outlook might look like, including how to spot warning signs of dehydration, protect kidney health, and plan hearing follow-up as needs change.
Long-term effects
Bartter disease type 4b can have lifelong effects centered on the kidneys, mineral balance, and hearing. Most people live into adulthood, but the condition may bring ongoing health needs over time. Long-term effects vary widely, and the course can differ even among people with the same diagnosis. What tends to matter over the years is how stable electrolytes remain, whether kidney changes develop, and the degree of hearing involvement.
Many have sensorineural hearing loss that’s present from infancy or early childhood. It may be mild to severe and can stay steady or slowly change. This can affect communication and learning in school years.
Babies and children may grow more slowly than peers, especially early on. Some reach a shorter adult height, while others come closer to average over time. Motor and language milestones are usually met but can be paced by hearing and health needs.
Calcium can build up in the kidneys (nephrocalcinosis), and some develop kidney stones. A portion of people experience gradual loss of kidney function leading to chronic kidney disease. The timing and pace of change vary from person to person.
Ongoing low potassium and related shifts can cause episodes of muscle weakness or cramps. Heart rhythm problems can occur when potassium drops very low. These episodes may flare during illness or stress.
How is it to live with Bartter disease type 4b?
Living with Bartter disease type 4b often means planning your day around hydration, salt and potassium supplements, and regular lab checks, while also watching for hearing differences that can affect communication and learning. Fatigue, muscle cramps, and frequent urination can shape routines at school, work, or travel, making easy bathroom access and flexible schedules especially helpful. Many families and partners become skilled at noticing early signs of dehydration or electrolyte shifts and supporting hearing needs, which can strengthen teamwork but also bring caregiver fatigue. With a consistent care plan, hearing support, and a responsive medical team, many people build stable routines and stay active in the parts of life that matter most to them.
Treatment and drugs
Treatment for Bartter disease type 4b focuses on easing salt loss, protecting the kidneys, and supporting hearing, since this form is linked with significant electrolyte wasting and sensorineural hearing loss. Doctors often use oral potassium and magnesium supplements, plus salt (sodium chloride) to correct ongoing losses; nonsteroidal anti-inflammatory drugs such as indomethacin are sometimes used to reduce kidney salt wasting, and a potassium‑sparing diuretic like spironolactone or amiloride may help limit potassium loss. Babies and children with Bartter disease type 4b often need careful fluid management, nutrition support, and close monitoring of growth, blood pressure, and blood levels of potassium, sodium, chloride, bicarbonate, and magnesium. Hearing management is a key part of care and may include early fitting of hearing aids or evaluation for cochlear implants, along with speech and language support. Not every treatment works the same way for every person, so your doctor may adjust your dose to balance benefits and side effects.
Non-drug treatment
Care focuses on keeping fluids and minerals steady, protecting hearing, and supporting growth and development over time. Because early symptoms of Bartter disease type 4b often include heavy urination and intense thirst, day-to-day care usually emphasizes hydration and salt replacement. Alongside medicines, non-drug therapies can make daily life safer and more comfortable. Plans are tailored with your care team and updated as needs change.
A structured drinking schedule helps offset frequent urination and thirst. Using water plus oral rehydration solutions can replace both fluid and salts.
Extra dietary salt helps replace what the kidneys lose. Your team will guide how much to add based on lab results and growth.
Foods like bananas, potatoes, and leafy greens can support potassium levels. Diet choices are an add-on to, not a replacement for, medical plans.
Balanced fluids with salts can prevent dehydration, especially during heat or illness. Keep packets or ready-made solutions available at home and school.
Your genes may have an impact on how drugs work for you
Genes can change how your body handles certain treatments for Bartter disease type 4b, affecting drug levels, side effects, and response. Pharmacogenetic testing and careful dose adjustments help clinicians choose safer, more effective options for electrolyte balance and hearing-related care.
Pharmacological treatments
For Bartter disease type 4b, medicines aim to replace the salts the kidneys lose and to calm the kidney signals that drive that loss. Even if early symptoms of Bartter disease type 4b began in infancy, treatment plans evolve as needs change over time. Not everyone responds to the same medication in the same way. Doctors adjust doses based on blood tests, growth, and day‑to‑day symptoms like thirst, cramps, and fatigue.
Replaces potassium lost in urine to ease cramps, weakness, and heart palpitations. Given as liquid, tablets, or sometimes IV in the hospital. Regular blood testing helps keep levels in a safe range.
Adds back the salt the kidneys waste to support hydration and growth. Can reduce dizziness, salt cravings, and frequent urination. Doses are tailored to lab results and fluid needs.
Correct low magnesium that can worsen muscle cramps and make potassium harder to maintain. May allow lower potassium doses. Can cause loose stools, so dosing is adjusted carefully.
Nonsteroidal anti‑inflammatory drugs can lower prostaglandins, which reduces kidney salt wasting and very high urine output. This may improve appetite and growth. Stomach and kidney side effects are monitored, and protective steps may be used.
Genetic influences
Bartter disease type 4b is most often caused by inherited changes in two related kidney genes that control salt balance (CLCNKA and CLCNKB). It follows a recessive, often “digenic,” pattern—meaning changes in two different genes are needed for the condition to appear, and for some, this also ties into hearing differences. A “carrier” means you hold the gene change but may not show symptoms. When each parent carries a change in one of these genes, there’s about a 1 in 4 (25%) chance in each pregnancy that a child will inherit both changes and develop Bartter disease type 4b; the exact risk can vary with the genes involved. Not every family will have an obvious history, so people often ask whether Bartter disease type 4b is inherited. Talking with a genetics professional about genetic testing for Bartter disease type 4b can clarify which genes are involved in your family and guide plans for siblings or future pregnancies.
Is Bartter disease type 4b genetic?
Genetics are central in Bartter disease type 4b. It’s usually caused by inherited changes in two partner genes (BSND plus CLCNKA or CLCNKB), typically in an autosomal recessive pattern. Variations influence severity, age at onset, electrolyte losses, and hearing involvement.
Pharmacogenetics—how genetics influence drug effects
In Bartter disease type 4b, the gene changes that disrupt how the kidneys handle salt also shape which medicines help most and which to avoid. Because prostaglandin levels run high, nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin or ibuprofen can reduce urine losses and support growth, but doses are chosen carefully to protect the kidneys and stomach. Potassium‑sparing options such as amiloride, spironolactone, or eplerenone may be added to limit potassium wasting, while loop or thiazide diuretics are generally avoided because they can worsen salt loss. Hearing can be sensitive in some people with Bartter disease type 4b, so doctors try to avoid medicines known to harm hearing, such as aminoglycoside antibiotics or loop diuretics, whenever possible. Common drug–gene differences outside of Bartter, such as changes in a liver enzyme gene that slow the breakdown of certain NSAIDs, can raise the chance of side effects with ibuprofen or similar drugs, so your care team may adjust the dose or choose another option. Genetic testing can sometimes identify how your body processes NSAIDs and other medicines, guiding safer, more effective treatment.
Interactions with other conditions
Day-to-day, people with Bartter disease type 4b may feel much worse when another illness causes fluid loss—like a stomach bug with vomiting or diarrhea—because salt and potassium can drop quickly, leading to cramps, fatigue, dizziness, or even heart rhythm problems. Medicines used for other conditions can interact, too: water pills (diuretics) and some laxatives increase salt loss, while certain antibiotics (especially aminoglycosides) and chemotherapy drugs can strain the kidneys and may worsen existing hearing issues. Doctors call it a “comorbidity” when two conditions occur together, and if someone also has chronic kidney disease, diabetes, or a heart rhythm disorder, electrolyte swings from Bartter disease type 4b can be harder to control and sometimes riskier. The anti-inflammatory medicines often used to manage Bartter symptoms (like indomethacin) can irritate the stomach and affect kidney blood flow, so they need extra caution if ulcers, inflammatory bowel disease, or reduced kidney function are present. Heat exposure, heavy sweating, or another salt-wasting condition can compound the problem, and early symptoms of Bartter disease type 4b can blur with signs of dehydration from a separate illness. Coordinated care among kidney, hearing, and primary care teams helps fine-tune fluids, salt supplements, and medications when another condition is in the mix.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies who didn’t gain weight, seemed constantly thirsty, and passed large amounts of urine, only later realizing the kidneys were losing vital salts. Families and communities once noticed patterns of similar symptoms in siblings, while hearing concerns about hearing loss in early childhood. In many places, caregivers tried extra feeds, broths, or salt, noticing brief improvement but no clear cure. These real-world clues hinted that Bartter disease type 4b affects both salt balance and hearing from very early life.
First described in the medical literature as part of the broader “Bartter syndromes,” the condition was initially grouped by shared signs—dehydration, low potassium, and normal blood pressure. Over time, descriptions became more precise as doctors recognized that some children also had sensorineural hearing loss. The “type 4” label grew out of this link between kidney salt wasting and hearing changes. Later, researchers noticed that a subset—now called type 4b—looked similar in the clinic but had a distinct genetic cause involving two partner proteins that move chloride in the kidney and the inner ear.
From early theories to modern research, the story of Bartter disease type 4b shifted from bedside observations to careful lab work. As medical science evolved, newborn screening programs, better electrolyte testing, and hearing assessments helped clinicians spot the combination of early salt loss and hearing differences. This allowed earlier supportive care, including salt and fluid strategies, while families received clearer explanations for symptoms that once seemed unrelated.
Advances in genetics confirmed what generations of similar symptoms had suggested: Bartter disease type 4b is inherited, and specific changes in two chloride channel genes must be present together to disrupt how the kidney concentrates urine and how the inner ear senses sound. In recent decades, knowledge has built on a long tradition of observation. Genetic testing moved the condition from a “look-alike” under the Bartter umbrella to its own, better-defined place, guiding counseling for parents and future pregnancies.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Knowing the condition’s history helps explain why some older reports used different labels or grouped children with and without hearing loss. It also shows why modern care pairs kidney management with prompt hearing evaluation. Today, many living with Bartter disease type 4b benefit from earlier diagnosis, coordinated care, and support tailored to both salt balance and hearing—progress that grew directly from careful observations made across families and across time.